bell
The current prices are delayed by 15 mins, login to check live prices.
Windlas Biotech Ltd share price logo

Windlas Biotech Share Price

(WINDLAS)

₹1007.30.31%

as on 04:01PM, 17 Jan 2025

Overview
News
Financials
Q3 2024 Results
Technicals

Windlas Biotech Performance

  • Day's Low

    Day's High

    ₹1,000
    Day's Price Range
    ₹1,049.55
  • 52 Week's Low

    52 Week's High

    ₹452.55
    52-Week Price Range
    ₹1,198.25
1 Month Return-4.67 %
3 Month Return-1.31 %
1 Year Return+ 109.29 %
Previous Close₹1,004.15
Open₹1,002.05
Volume45.81K
Upper Circuit-
Lower Circuit-
Market Cap₹2,098.70Cr

Windlas Biotech Key Statistics

P/E Ratio34.27
PEG Ratio4.73
Market Cap₹2,098.70 Cr
P/B Ratio2.37
EPS27.98
Dividend Yield1.07
SectorPharmaceuticals
ROE13.63

Windlas Biotech Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹2,098.70 Cr29.48%0.51₹58 Cr₹630 Cr
NA₹10.17 Cr94.34%0.88NANA
NA₹261.26 Cr97.58%0.52₹16 Cr₹108 Cr
NA₹122.53 Cr40.58%0.51NANA
NA₹14,909.73 Cr-1.26%0.73₹82 Cr₹1,465 Cr

About Windlas Biotech

Windlas Biotech Ltd was founded in 2001 and is a leading provider of pharmaceutical services, development, manufacturing services, and products. The company has a manufacturing plant in Dehradun, Uttarakhand, India and a sales force and distribution network across 14 states. Additionally, it provides CDMO services and products, domestic trade generics and OTC brands, and exports. The company specializes in complex generics products and fixed dose combinations linked to lifestyle-related diseases, as well as drug-device combos. It has adopted high quality systems across its factories and processes that span from product innovation to customer intake. In addition to this, multiple vendors are approved and assessed for sourcing the raw materials.

Share Price: ₹1007.30 per share as on 17 Jan, 2025 04:01 PM
Market Capitalisation: ₹2,098.70Cr as of today
Revenue: ₹187.00Cr as on September 2024 (Q3 24)
Net Profit: ₹15.66Cr as on September 2024 (Q3 24)
Listing date: 16 Aug, 2021
Chairperson Name: Vivek Dhariwal
OrganisationWindlas Biotech
HeadquartersGurgaon
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Windlas Biotech Ltd

  • Windlas Biotech Achieves GMP Certification for Injectable Facility - 10 Jan, 2025

    Windlas Biotech announced that its new injectable manufacturing facility has received GMP certification, confirming compliance with WHO guidelines. This certification enhances the company's manufacturing capabilities and positions it to meet growing demand for injectable products.

Insights on Windlas Biotech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, WINDLAS stock has moved up by 33.7%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 8 quarters, 121.87 Cr → 191.84 Cr (in ₹), with an average increase of 6.2% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 13.48 Cr → 15.66 Cr (in ₹), with an average increase of 13.9% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 25.55% to 25.91% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 1.59% to 2.00% in Sep 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 62.51% of holdings in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 8.70% to 7.57% in Sep 2024 quarter

Windlas Biotech Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹152.67Cr (-)₹162.21Cr (↑6.25%)₹171.29Cr (↑5.60%)₹175.15Cr (↑2.25%)₹187.00Cr (↑6.77%)
Net Income₹14.03Cr (-)₹15.10Cr (↑7.63%)₹16.99Cr (↑12.52%)₹13.48Cr (↓20.66%)₹15.66Cr (↑16.17%)
Net Profit Margin9.19% (-)9.31% (↑1.31%)9.92% (↑6.55%)7.70% (↓22.38%)8.37% (↑8.70%)
Value in ₹ crore
Details2021202220232024
Total Assets₹296.00Cr (-)₹492.07Cr (↑66.24%)₹530.64Cr (↑7.84%)₹628.91Cr (↑18.52%)
Total Liabilities₹97.01Cr (-)₹96.94Cr (↓0.07%)₹127.98Cr (↑32.02%)₹178.62Cr (↑39.57%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹20.87Cr (-)₹11.45Cr (↓45.14%)₹9.00Cr (↓21.40%)₹60.98Cr (↑577.56%)₹108.91Cr (↑78.60%)

Index Inclusions

BSE Healthcare

₹42,660.26

0.22 (95.19%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

BSE Small-Cap

₹52,311.31

0.01 (2.64%)

Windlas Biotech Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
62.51%
0.00
Foreign Institutions
2%
25.65
Mutual Funds
7.57%
-12.95
Retail Investors
25.91%
1.39
Others
2.01%
22.00

Windlas Biotech Key Indicators

Details20202021202220232024
Return On Equity %10.949.3912.9810.6913.63
Details20202021202220232024
Return On Assets %4.715.357.748.039.25
Details202220232024
Book Value Per Share (₹)181.14192.24216.34
Details202220232024
Earning Per Share (₹)17.4820.3727.98

Windlas Biotech Valuation

Windlas Biotech in the last 5 years

  • Overview

  • Trends

Lowest (10.46x)

March 28, 2023

Today (34.27x)

January 17, 2025

Industry (54.95x)

January 17, 2025

Highest (38.93x)

December 6, 2024

LowHigh

Windlas Biotech Earnings and Dividends

  • Windlas Biotech Ltd Earnings Results

    Windlas Biotech Ltd’s net profit jumped 11.62% since last year same period to ₹15.66Cr in the Q2 2024-2025. On a quarterly growth basis, Windlas Biotech Ltd has generated 16.17% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Windlas Biotech Ltd Dividends May,2024

    In the quarter ending March 2024, Windlas Biotech Ltd has declared dividend of ₹5.50 - translating a dividend yield of 0.55%.

    Read More about Dividends

Windlas Biotech Technicals Summary

Bearish

Neutral

Bullish

Bearish

Windlas Biotech Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Windlas Biotech Ltd

Windlas Biotech Ltd share price today stands at ₹1007.3, Open. ₹1002.05 ; Previous Close. ₹1004.15 ; High. ₹1049.55 ; Low. ₹1000 ; 52 Week High. ₹1198.25 ; 52 Week Low: ₹452.55.

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Windlas Biotech Ltd shares.

Windlas Biotech Ltd is listed on NSE

Windlas Biotech Ltd is listed on BSE

  • Today’s highest price of Windlas Biotech Ltd is ₹1049.55.
  • Today’s lowest price of Windlas Biotech Ltd is ₹1000.

PE Ratio of Windlas Biotech Ltd is 34.27

PE ratio = Windlas Biotech Ltd Market price per share / Windlas Biotech Ltd Earnings per share

Today’s traded volume of Windlas Biotech Ltd(WINDLAS) is 45.81K.

Today’s market capitalisation of Windlas Biotech Ltd(WINDLAS) is ₹2098.7Cr.

Windlas Biotech Ltd(WINDLASPrice
52 Week High
₹1198.25
52 Week Low
₹452.55

Windlas Biotech Ltd(WINDLAS) share price is ₹1007.3. It is down -15.94% from its 52 Week High price of ₹1198.25

Windlas Biotech Ltd(WINDLAS) share price is ₹1007.3. It is up 122.58% from its 52 Week Low price of ₹452.55

Windlas Biotech Ltd(WINDLASReturns
1 Day Returns
3.15%
1 Month Returns
-4.67%
3 Month Returns
-1.31%
1 Year Returns
109.29%